Anti-myelin associated glycoprotein (mag) antibodies
CA 2494008 C · Owner: Ellis, Jonathan Henry · Inventors: Ellis, Jonathan Henry; Germaschewski, Volker
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to altered antibodies to myelin associated glycoprotein (MAG), pharmaceutical formulations containing them and to the use of such antibodies in the treatment and/or prophylaxis of neurological diseases/disorders.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 5, 2003 and granted December 11, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 5, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 5, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.